中文版 | English

个人主页

关键词云

成果统计

合作作者[TOP 5]

  • 彭博

    合作成果数：13

  • 合作成果数：11

  • 宋天瑜

    合作成果数：8

  • Liu, Jiye

    合作成果数：8

  • Zhou, Wenrong

    合作成果数：7

访问统计


  总访问量
 3511
  访问来源
    内部： 18
    外部： 3493
    国内： 3204
    国外： 307

  年访问量
 459
  访问来源
    内部： 5
    外部： 454
    国内： 440
    国外： 19

  月访问量
 74
  访问来源
    内部： 0
    外部： 74
    国内： 73
    国外： 1

访问量

访问量

1. CRL4 antagonizes SCFFbxo7-mediated turnover of cereblon and BK cha.. [1648]
2. ERK signaling mediates resistance to immunomodulatory drugs in the.. [926]
3. Restriction of hepatitis B virus replication by c-Abl-induced prot.. [708]
4. A genome-scale CRISPR-Cas9 screening in myeloma cells identifies r.. [623]
5. Addressing the Enzyme-independent tumor-promoting function of NAMP.. [616]
6. Tumor evolution selectively inactivates the core microRNA machiner.. [583]
7. PPI-Miner: A Structure and Sequence Motif Co-Driven Protein-Protei.. [554]
8. Genome-Wide CRISPR-Cas9 Screening Reveals a Role for TRAF2 in Resi.. [513]
9. mTOR抑制剂增强靶向蛋白降解药物功效的应用 [451]
10. 一种可降解蛋白的并环类化合物及其应用 [448]
11. 一种CRBN基因人源化动物肿瘤细胞模型的构建方法和用途 [447]
12. 一种预测肝癌肺转移的生物标志物及其应用 [393]
13. FUSED CYCLIC COMPOUND CAPABLE OF DEGRADING PROTEIN AND USE THEREOF [388]
14. The DDB1-DCAF2 complex is essential for B cell development because.. [380]
15. Lenalidomide bypasses CD28 co-stimulation to reinstate PD-1 immuno.. [364]
16. mTOR抑制剂增强靶向蛋白降解药物功效的应用 [363]
17. Mini PROTACs: N-End Rule-Mediated Degradation on the Horizon [358]
18. FUSED CYCLIC COMPOUND CAPABLE OF DEGRADING PROTEIN AND USE THEREOF [352]
19. Routes to molecular glue degrader discovery [351]
20. FUSED CYCLIC COMPOUND CAPABLE OF DEGRADING PROTEIN AND USE THEREOF [349]
21. TRAF2 mediates sensitivity to immunomodulatory drugs via NF-kappa .. [336]
22. USE OF CRBN GENE IN CONSTRUCTION OF GSPT1 SENSITIVE MODEL [330]
23. Crbn基因在构建GSPT1敏感模型中的用途 [329]
24. Cancer driver screens identifyregulators of immune checkpoint bloc.. [299]
25. Addressing Enzymatic-Independent Tumor-Promoting Function of NAMPT.. [292]
26. 来那度胺或其类似物在作为免疫调节剂中的应用 [291]
27. Tumor evolution selectively inactivates microRNA machinery for imm.. [257]
28. Immune pressure selects ANKRD52 mutations for cancer cells to esca.. [243]
29. TRAF2 mediates sensitivity to immunomodulatory drugs via NF-kappa .. [187]
30. 组蛋白H3泛素化通过影响H3K9甲基化进而调控肝脏发育相关基因表达的机制 [180]
31. Loss of SGK1 supports metastatic colonization in hepatocellular ca.. [101]

下载量

1. CRL4 antagonizes SCFFbxo7-mediated turnover of cereblon and BK cha.. [461]
2. ERK signaling mediates resistance to immunomodulatory drugs in the.. [283]
3. Tumor evolution selectively inactivates the core microRNA machiner.. [218]
4. Addressing Enzymatic-Independent Tumor-Promoting Function of NAMPT.. [101]
5. Restriction of hepatitis B virus replication by c-Abl-induced prot.. [28]
6. Addressing the Enzyme-independent tumor-promoting function of NAMP.. [27]
7. Loss of SGK1 supports metastatic colonization in hepatocellular ca.. [11]
8. PPI-Miner: A Structure and Sequence Motif Co-Driven Protein-Protei.. [5]
9. mTOR抑制剂增强靶向蛋白降解药物功效的应用 [4]
10. Mini PROTACs: N-End Rule-Mediated Degradation on the Horizon [4]
11. Crbn基因在构建GSPT1敏感模型中的用途 [3]
12. Lenalidomide bypasses CD28 co-stimulation to reinstate PD-1 immuno.. [3]
13. A genome-scale CRISPR-Cas9 screening in myeloma cells identifies r.. [2]
14. Tumor evolution selectively inactivates microRNA machinery for imm.. [2]
15. 一种预测肝癌肺转移的生物标志物及其应用 [1]
16. 来那度胺或其类似物在作为免疫调节剂中的应用 [1]
17. FUSED CYCLIC COMPOUND CAPABLE OF DEGRADING PROTEIN AND USE THEREOF [1]
18. FUSED CYCLIC COMPOUND CAPABLE OF DEGRADING PROTEIN AND USE THEREOF [1]
19. FUSED CYCLIC COMPOUND CAPABLE OF DEGRADING PROTEIN AND USE THEREOF [1]
20. Routes to molecular glue degrader discovery [1]